chr17-18148928-C-A

Variant summary

Our verdict is Benign. Variant got -10 ACMG points: 2P and 12B. PM2BP4_StrongBP6_Very_Strong

The NM_016239.4(MYO15A):​c.6932C>A​(p.Ala2311Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000965 in 1,450,278 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000097 ( 0 hom. )

Consequence

MYO15A
NM_016239.4 missense

Scores

19

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.0260
Variant links:
Genes affected
MYO15A (HGNC:7594): (myosin XVA) This gene encodes an unconventional myosin. This protein differs from other myosins in that it has a long N-terminal extension preceding the conserved motor domain. Studies in mice suggest that this protein is necessary for actin organization in the hair cells of the cochlea. Mutations in this gene have been associated with profound, congenital, neurosensory, nonsyndromal deafness. This gene is located within the Smith-Magenis syndrome region on chromosome 17. Read-through transcripts containing an upstream gene and this gene have been identified, but they are not thought to encode a fusion protein. Several alternatively spliced transcript variants have been described, but their full length sequences have not been determined. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -10 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.035473883).
BP6
Variant 17-18148928-C-A is Benign according to our data. Variant chr17-18148928-C-A is described in ClinVar as [Likely_benign]. Clinvar id is 164545.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
MYO15ANM_016239.4 linkuse as main transcriptc.6932C>A p.Ala2311Glu missense_variant 33/66 ENST00000647165.2 NP_057323.3 Q9UKN7-1
MYO15AXM_017024715.3 linkuse as main transcriptc.6935C>A p.Ala2312Glu missense_variant 31/64 XP_016880204.1
MYO15AXM_017024714.3 linkuse as main transcriptc.6872C>A p.Ala2291Glu missense_variant 30/63 XP_016880203.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
MYO15AENST00000647165.2 linkuse as main transcriptc.6932C>A p.Ala2311Glu missense_variant 33/66 NM_016239.4 ENSP00000495481.1 Q9UKN7-1
MYO15AENST00000578999.1 linkuse as main transcriptn.444C>A non_coding_transcript_exon_variant 3/45

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD3 exomes
AF:
0.00000891
AC:
2
AN:
224364
Hom.:
0
AF XY:
0.0000164
AC XY:
2
AN XY:
122192
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000199
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000965
AC:
14
AN:
1450278
Hom.:
0
Cov.:
34
AF XY:
0.0000125
AC XY:
9
AN XY:
720334
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000181
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.0000508
Hom.:
0
Bravo
AF:
0.00000378
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Likely benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineAug 30, 2013Ala2311Glu in Exon 33 of MYO15A: This variant is not expected to have clinical significance because the alanine (Ala) amino acid residue at position 2311 is no t conserved, with wallaby and opossum having a glutamic acid (Glu). -
not provided Benign:1
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.092
BayesDel_addAF
Benign
-0.17
T
BayesDel_noAF
Benign
-0.48
CADD
Benign
0.058
DANN
Benign
0.97
DEOGEN2
Benign
0.026
T;T;T
Eigen
Benign
-1.6
Eigen_PC
Benign
-1.5
FATHMM_MKL
Benign
0.030
N
LIST_S2
Benign
0.14
T;.;T
M_CAP
Benign
0.055
D
MetaRNN
Benign
0.035
T;T;T
MetaSVM
Benign
-0.84
T
MutationAssessor
Benign
0.42
.;N;N
PrimateAI
Benign
0.29
T
PROVEAN
Benign
-0.81
.;N;.
REVEL
Benign
0.20
Sift
Benign
0.48
.;T;.
Sift4G
Benign
0.50
T;T;.
Polyphen
0.0
.;B;B
Vest4
0.075
MutPred
0.29
Gain of disorder (P = 0.0546);Gain of disorder (P = 0.0546);Gain of disorder (P = 0.0546);
MVP
0.24
ClinPred
0.034
T
GERP RS
-0.39
Varity_R
0.071
gMVP
0.42

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs727503314; hg19: chr17-18052242; API